Company intelligence / Profile preview

Next Life Sciences

San Luis Obispo, California, United Statesnextlifesciences.org ↗

Ownership: Private
Development stage: Preclinical

Overview

Plan A™, the company's lead program, has shown promising preclinical results demonstrating effective and reversible male contraception using a non-hormonal hydrogel injected into the vas deferens. Restoration of sperm flow was rapid after dissolving the gel in animal studies. The company initiated first-in-human clinical trials in early 2024 and plans larger pivotal studies toward FDA submission and potential market launch by ~2027. No peer-reviewed human efficacy data published as of June 2025.

Therapeutic areas: Men's Health
Modalities: DeviceHydrogel-based drug delivery therapy (specifically hydrogel occlusion of vas deferens)
Industry: Implantable Medical Devices

Drug pipeline

1 asset

Plan A

Pre-clinical

Indications: Male contraception

Partnerships

Parsemus Foundation (originator/developer of Vasalgel®, now licensed/acquired by Next Life Sciences)

Beyond the preview

Go deeper on Next Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Next Life Sciences.